Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China flag China · Delayed Price · Currency is CNY
18.68
+0.23 (1.25%)
Apr 24, 2026, 3:04 PM CST
Market Cap8.68B -23.2%
Revenue (ttm)1.87B -37.8%
Net Income-167.76M
EPS-0.35
Shares Out464.53M
PE Ration/a
Forward PE20.87
Dividend0.40 (2.17%)
Ex-Dividend DateMay 20, 2025
Volume11,335,754
Average Volume5,068,429
Open17.74
Previous Close18.45
Day's Range17.74 - 18.86
52-Week Range17.33 - 26.29
Beta1.06
RSI54.32
Earnings DateApr 23, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney... [Read more]

Sector Healthcare
Founded 1992
Employees 3,197
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300482
Full Company Profile

Financial Performance

Financial Statements